EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.4.2.1 | 1,5-O-bis(N-benzyloxycarbonylglycyl)-2,3-O-isopropylidene beta-D-riboside | - |
Homo sapiens | |
2.4.2.1 | 1-[2,3-O-isopropylidene-D-ribofuranosyl]-1,4-dihydropyridine-3-carboxamide | - |
Homo sapiens | |
2.4.2.1 | 3-carbamoyl-1-[2,3-O-isopropylidene-D-ribofuranosyl]pyridin-1-ium | - |
Homo sapiens | |
2.4.2.1 | nicotinamide 5-O-glycyl-beta-D-riboside | - |
Homo sapiens | |
2.4.2.1 | nicotinamide 5-O-L-isoleucyl-beta-D-riboside | - |
Homo sapiens | |
2.4.2.1 | nicotinamide 5-O-L-leucyl-beta-D-riboside | - |
Homo sapiens | |
2.4.2.1 | nicotinamide 5-O-L-methionyl-beta-D-riboside | - |
Homo sapiens | |
2.4.2.1 | nicotinamide 5-O-L-tryptophanyl-beta-D-riboside | - |
Homo sapiens | |
2.4.2.1 | nicotinamide 5-O-L-tyrosinyl-beta-D-riboside | - |
Homo sapiens | |
2.4.2.1 | nicotinamide 5-O-L-valyl-beta-D-riboside | - |
Homo sapiens | |
2.4.2.1 | reduced nicotinamide 5-O-(N-tert-butyloxycarbonyl-L-isoleucyl)-2,3-O-isopropylidene beta-D-riboside | - |
Homo sapiens | |
2.4.2.1 | reduced nicotinamide 5-O-(N-tert-butyloxycarbonyl-L-leucyl)-2,3-O-isopropylidene beta-D-riboside | - |
Homo sapiens | |
2.4.2.1 | reduced nicotinamide 5-O-(N-tert-butyloxycarbonyl-L-methionyl)-2,3-O-isopropylidene beta-D-riboside | - |
Homo sapiens | |
2.4.2.1 | reduced nicotinamide 5-O-(N-tert-butyloxycarbonyl-L-tyrosinyl)-2,3-O-isopropylidene beta-D-riboside | - |
Homo sapiens | |
2.4.2.1 | reduced nicotinamide 5-O-(N-tert-butyloxycarbonyl-L-valyl)-2,3-O-isopropylidene beta-D-riboside | - |
Homo sapiens | |
2.4.2.1 | reduced nicotinamide 5-O-(N-tert-butyloxycarbonylglycyl)-2,3-O-isopropylidene beta-D-riboside | - |
Homo sapiens | |
2.4.2.1 | reduced nicotinamide 5-O-(N1,Nalpha-bis(tert-butyloxycarbonyl)-L-tryptophanyl)-2,3-O-isopropylidene beta-D-riboside | - |
Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.2.1 | Homo sapiens | P00491 | - |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.2.1 | additional information | the nutraceutical nicotinamide riboside (NR), an efficacious biosynthetic precursor to NAD, is readily metabolized by the purine nucleoside phosphorylase (PNP). Access to the PNP-stable versions of NR is difficult because the glycosidic bond of NR is easily cleaved. Unlike NR, NRH, the reduced form of NR, offers sufficient chemical stability to allow the successful functionalisation of the ribosyl-moiety. A series of NRH and NR derived amino acid conjugates is generated in good to excellent yields and show that O5'-esterification prevents the PNP-catalyzed phosphorolysis of these NR prodrugs, overview. Enzyme PNP catalyzes the phosphorolysis of nicotinamide riboside chloride (NR-Cl) and glycine nicotinamide riboside conjugate (Gly-NR) | Homo sapiens | ? | - |
- |
|
2.4.2.1 | nicotinamide riboside + phosphate | - |
Homo sapiens | nicotinamide + alpha-D-ribose 1-phosphate | - |
r |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.4.2.1 | PNP | - |
Homo sapiens |
2.4.2.1 | purine nucleoside phosphorylase | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
2.4.2.1 | 22 | - |
assay at room temperature | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.4.2.1 | 7 | - |
assay at | Homo sapiens |